Shaping the Future Today: An Insight Brief on Rize, Inc.
By: Eric Luyer, Industry Research Analyst, & Ellyn McMullin, Research Associate
The interest around 3D Printing or Additive Manufacturing has risen spectacularly the last few years. The use of 3D Printing technology has wide-ranging applications in surgery, healthcare, pharmaceutical and medical device industries and works as a catalyst for personalized medicine, diagnostics, as well as for training or learning practices. With the use of 3D Printing, Life Sciences companies can break through barriers using new methods of manufacturing processes or using new materials to create unique offerings and can achieve market differentiation.
In Life Sciences, RIZE, Inc., has succeeded in Preclinical Pharmaceutical and Medical Device applications due to the advantages of their unique process.
“Our RIZE 3D printing platform, with its clean process, clean materials and completely safe user experience, makes it very suitable for the Life Sciences industry,” said Andy Kalambi, President and CEO of RIZE. “As a result, we are delighted to see the variety of functional use cases in pre-clinical applications developed by our customers. They continue to push the envelope and discover new ways to put the technology to use, cut costs and improve products in ways never seen before in the 3D Printing industry.”
Our insight brief covers:
- 3D Printers – Components and Capabilities
- Next Generation 3D Printing
- Improving Outcomes While Meeting the Regulatory Baseline
- How CONMED, a global Medical Device manufacturer turned to RIZE, in part, for a unique application – to print molds to produce elastomeric products.
Register here to learn how Life-Science companies are experiencing significant benefits using 3D Printing technologies for complex, additive manufacturing processes in a regulated environment.